A Pharmacokinetics Study to Investigate the Effect of Ketoconazole on Vemurafenib in Patients With BRAFV600 Mutation-Positive Metastatic Melanoma

Clinical trial NCT01765556 · WITHDRAWN

Trial details

NCT number: NCT01765556
Sponsor: Hoffmann-La Roche
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Melanoma, Neoplasms

Start date: 2013-10-01
Primary completion: 2013-10-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.